Lasofoxifene - Investigational Treatment

About

Lasofoxifene is a selective estrogen receptor modulator (SERM) that has been investigated for the treatment of menopausal symptoms and postmenopausal osteoporosis. While approved in some countries, it is still investigational in the United States.

Efficacy

Clinical trials demonstrated efficacy in preventing bone loss and treating vulvar and vaginal atrophy without stimulating endometrial tissue

Targets Symptoms